It is a paper private limited company based in New Delhi, Delhi, India, established in 2023.
2023 | New Delhi, Delhi, India | ActiveDockit Bioclinical Technologies Private Limited, a active private limited company, was established on 26 May 2023 in New Delhi, Delhi, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002DL2023PTC414740. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹30.00 K .
Its leadership includes Shruti Kaushik (Director), Shadaan Ahmad (Director). Past directors included Chander Shekhar. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 716, Seventh Floor, Dlf Prime Towers, Okhla Phase 1, New Delhi, Delhi, 110020.
U21002DL2023PTC414740
414740
26 May 2023
₹1.50 M
₹30.00 K
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dockit Bioclinical Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shruti Kaushik | Director | 26 May 2023 | Current |
| Shadaan Ahmad | Director | 11 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Dockit Bioclinical Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Dockit Bioclinical Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dockit Bioclinical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dockit Bioclinical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dockit Bioclinical Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shadaan Ahmad was appointed as a Director was appointed as a Director on 11 Jul 2025 & has been associated with this company since 4 months 24 days . was recorded as a recent event.
Progress on Dockit Bioclinical Technologies Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
The activity Dockit Bioclinical Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Shruti Kaushik was appointed as a Director was appointed as a Director on 26 May 2023 & has been associated with this company since 2 years 6 months . was documented.
Dockit Bioclinical Technologies Private Limited was registered on 26 May 2023 with Roc Delhi & aged 2 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Dockit Bioclinical Technologies Private Limited is U21002DL2023PTC414740.
Dockit Bioclinical Technologies Private Limited is headquartered at 716, Seventh Floor, Dlf Prime Towers, Okhla Phase 1, New Delhi, Delhi, 110020.
Dockit Bioclinical Technologies Private Limited was incorporated on 26 May 2023.
The current directors of Dockit Bioclinical Technologies Private Limited are
The primary industry of Dockit Bioclinical Technologies Private Limited is Paper.
Dockit Bioclinical Technologies Private Limited is unlisted.
The authorized capital of Dockit Bioclinical Technologies Private Limited is ₹1.50 M, and the paid-up capital is ₹30.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX